Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Five Hospital of the Alpine Region
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 3,500
- 试验地点
- 1
- 主要终点
- SARS-CoV-2 prevalency among hospital health care professionals
研究概览
简要总结
The PACAAP study aims to report the seroprevalence of SARS-CoV-2 IgG antibodies among HCWs testing during the massive campaign screening set up in France by French ministry of Health and national authorities in four hospital of the Alpine region.
详细描述
In France during the first wave of the pandemic, 30,230 symptomatic healthcare workers had been reported positive. Yet, the prevalence of the infection in French healthcare workers remains unknown as it mostly reflect symptomatic infections.
Also, the prevalence of infection was reported being higher in male healthcare workers, and in those having patients' facing roles. However, the impact of the level of exposure to SARS-CoV-2, the use of personal protective equipment and hospital organization to prevent infection and spread remains unclear.
Our study aims to report the seroprevalence of SARS-CoV-2 infection among French healthcare workers after the first wave of the pandemic. It also aims to explore the impact of the type of occupations and the level of exposure to the viruses on the seroprevalence of infection.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hospital staff employee
- •Employed in one of the participating centers
- •Volunteers to perform SARS-CoV-2 serology
- •Permanent or occasional staff (temporary workers, short contracts)
- •Caregivers or not (medical, paramedical, administrative, technical staff)
排除标准
- •Staff who are not working at a participating center while participating in the study
- •Person under guardianship or curatorship
- •Opposition to data collection
结局指标
主要结局
SARS-CoV-2 prevalency among hospital health care professionals
时间窗: Day 1
Number of Health Care Worker with an antibody test (IgG) positive for SARS-CoV2
次要结局
未报告次要终点